Top

Published in:

01-02-2013 | Review Article

Influenza-Associated Neurological Complications

Authors: Jenny P. Tsai, Andrew J. Baker

Published in: Neurocritical Care | Issue 1/2013

Abstract

While mostly diagnosed in the pediatric population, neurological complications of pandemic influenza A infection may affect young and previously healthy adults, and may follow a fulminant, severe, and occasionally fatal course. We reviewed severe neurological complications secondary to influenza infection reported in the literature, in attempt to outline recurrent syndromes that may assist the clinician in making a timely diagnosis. Vigilance and awareness of these clinical entities are key in the neurologist and intensivist’s role in surveillance and early recognition of pandemic influenza, and in ensuring improved survival for affected patients.

Agyeman P, Duppenthaler A, Heininger U, Aebi C. Influenza-associated myositis in children. Infection. 2004;32(4):199–203.PubMedCrossRef

Aiba H, Mochizuki M, Kimura M, Hojo H. Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy. Neurology. 2001;57(2):295–9.PubMedCrossRef

Akins PT, Belko J, Uyeki TM, Axelrod Y, Lee KK, Silverthorn J. H1N1 encephalitis with malignant edema and review of neurologic complications from influenza. Neurocrit Care. 2010;13(3):396–406.PubMedCrossRef

Amin R, Ford-Jones E, Richardson SE, MacGregor D, Tellier R, Heurter H, Fearon M, Bitnun A. Acute childhood encephalitis and encephalopathy associated with influenza: a prospective 11 year review. Pediatr Infect Dis J. 2008;27(5):390–5.PubMedCrossRef

Auriel E, Gadoth A, Regev K, et al. Seasonal and H1N1v influenza vaccines in MS: safety and compliance. J Neurol Sci. 2012;314(1–2):102–3.PubMedCrossRef

Bacon CJ, Hall SM. Haemorrhagic shock encephalopathy syndrome in the British Isles. Arch Dis Child. 1992;67(8):985–93.PubMedCrossRef

Bardage C, Persson I, Ortgvist A, et al. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm. Sweden BMJ. 2011;343:d5956.CrossRef

Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362(18):1708–19.PubMedCrossRef

Berger JR, Houff SA. Neurological infections: the year of PML and influenza. Lancet Neurol. 2010;9(1):14–7.PubMedCrossRef

10.

Black S, Eskola J, Siegrist CA, Halsey N, Macdonald N, Law B, Miller E, Andrews N, Stowe J, Salmon D, et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet. 2009;374(9707):2115–22.PubMedCrossRef

11.

Chen YC, Lo CP, Chang TP. Novel influenza A (H1N1)-associated encephalopathy/encephalitis with severe neurological sequelae and unique image features–a case report. J Neurol Sci. 2010;298(1–2):110–3.PubMedCrossRef

12.

Davis LE. Neurologic and muscular complications of the 2009 influenza A (H1N1) pandemic. Curr Neurol Neurosci Rep. 2010;10(6):476–83.PubMedCrossRef

13.

de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH, Beld M, Le TP, Truong HK, Nguyen VV, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med. 2005;352(7):686–91.PubMedCrossRef

14.

de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006;12(10):1203–7.PubMedCrossRef

15.

Destefano F, Tokars J. H1N1 vaccine safety monitoring: beyond background rates. Lancet. 2010;375(9721):1146–7.PubMedCrossRef

16.

Drago L, Attia MW, DePiero A, Bean C. Influenza A-associated meningoencephalitis. Pediatr Emerg Care. 2005;21(7):437–9.PubMedCrossRef

17.

Eisen DP, McBryde ES. Avoiding Guillan-Barre Syndrome following swine origin pandemic H1N1 2009 influenza vaccination. J Infect Dis. 2009;200(10):1627–8.PubMedCrossRef

18.

Evans D, Cauchemez S, Hayden FG. “Prepandemic” immunization for novel influenza viruses, “swine flu” vaccine, Guillain-Barre syndrome, and the detection of rare severe adverse events. J Infect Dis. 2009;200(3):321–8.PubMedCrossRef

19.

Finsterer J, Artner C, Kladosek A, Kalchmayr R, Redtenbacher S. Cavernous sinus syndrome due to vaccination-induced giant cell arteritis. Arch Intern Med. 2001;161(7):1008–9.PubMedCrossRef

20.

Fluss J, Ferey S, Menache-Starobinski C, Delavelle J, Van Bogaert P, Vargas MI. Mild influenza-associated encephalopathy/encephalitis with a reversible splenial lesion in a Caucasian child with additional cerebellar features. Eur J Paediatr Neurol. 2010;14(1):97–100.PubMedCrossRef

21.

Foley PB. Encephalitis lethargica and the influenza virus. II. The influenza pandemic of 1918/19 and encephalitis lethargica: epidemiology and symptoms. J Neural Transm. 2009;116(10):1295–308.PubMedCrossRef

22.

Foley PB. Encephalitis lethargica and the influenza virus. III. The influenza pandemic of 1918/19 and encephalitis lethargica: neuropathology and discussion. J Neural Transm. 2009;116(10):1309–21.PubMedCrossRef

23.

Fugate JE, Lam EM, Rabinstein AA, Wijdicks EF. Acute hemorrhagic leukoencephalitis and hypoxic brain injury associated with H1N1 influenza. Arch Neurol. 2010;67(6):756–8.PubMedCrossRef

24.

Fujimoto S, Kobayashi M, Uemura O, Iwasa M, Ando T, Katoh T, Nakamura C, Maki N, Togari H, Wada Y. PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis. Lancet. 1998;352(9131):873–5.PubMedCrossRef

25.

Ganapathy S, Ey EH, Wolfson BJ, Khan N. Transient isolated lesion of the splenium associated with clinically mild influenza encephalitis. Pediatr Radiol. 2008;38(11):1243–5.PubMedCrossRef

26.

Gefen R, Eshel G, Abu-Kishk I, Lahat E, Youngster I, Rosenbloom E, Kozer E. Hemorrhagic shock and encephalopathy syndrome: clinical course and neurological outcome. J Child Neurol. 2008;23(5):589–92.PubMedCrossRef

27.

Gika AD, Rich P, Gupta S, Neilson DE, Clarke A. Recurrent acute necrotizing encephalopathy following influenza A in a genetically predisposed family. Dev Med Child Neurol. 2010;52(1):99–102.PubMedCrossRef

28.

Gooskens J, Kuiken T, Claas EC, Harinck HI, Thijssen JC, Baelde HJ, Kroes AC. Severe influenza resembling hemorrhagic shock and encephalopathy syndrome. J Clin Virol. 2007;39(2):136–40.PubMedCrossRef

29.

Hidaka F, Matsuo S, Muta T, Takeshige K, Mizukami T, Nunoi H. A missense mutation of the Toll-like receptor 3 gene in a patient with influenza-associated encephalopathy. Clin Immunol. 2006;119(2):188–94.PubMedCrossRef

30.

Honorat R, Tison C, Sevely A, et al. Influenza A(H1N1)-associated ischemic stroke in a 9-month-old child. Pediatr Emerg Care. 2012;28(4):368–9.PubMedCrossRef

31.

Hosoya M, Kawasaki Y, Katayose M, Sakuma H, Watanabe M, Igarashi E, Aoyama M, Nunoi H, Suzuki H. Prognostic predictive values of serum cytochrome c, cytokines, and other laboratory measurements in acute encephalopathy with multiple organ failure. Arch Dis Child. 2006;91(6):469–72.PubMedCrossRef

32.

Hosoya M, Nunoi H, Aoyama M, Kawasaki Y, Suzuki H. Cytochrome c and tumor necrosis factor-alpha values in serum and cerebrospinal fluid of patients with influenza-associated encephalopathy. Pediatr Infect Dis J. 2005;24(5):467–70.PubMedCrossRef

33.

Huang YC, Lin TY, Wu SL, Tsao KC. Influenza A-associated central nervous system dysfunction in children presenting as transient visual hallucination. Pediatr Infect Dis J. 2003;22(4):366–8.PubMed

34.

Hull JH, Mead SH, Foster OJ, Modarres-Sadeghi H. Severe vasculitic neuropathy following influenza vaccination. J Neurol Neurosurg Psychiatry. 2004;75(10):1507–8.PubMedCrossRef

35.

Huynh W, Cordato DJ, Kehdi E, Masters LT, Dedousis C. Post-vaccination encephalomyelitis: literature review and illustrative case. J Clin Neurosci. 2008;15(12):1315–22.PubMedCrossRef

36.

Ichiyama T, Isumi H, Ozawa H, Matsubara T, Morishima T, Furukawa S. Cerebrospinal Fluid and Serum Levels of Cytokines and Soluble Tumor Necrosis Factor Receptor in Influenza Virus-associated Encephalopathy. Scand J Infect Dis. 2003;35(1):59–61.PubMedCrossRef

37.

Ichiyama T, Morishima T, Kajimoto M, Matsushige T, Matsubara T, Furukawa S. Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy. Pediatr Infect Dis J. 2007;26(6):542–4.PubMedCrossRef

38.

Ichiyama T, Morishima T, Suenaga N, Kajimoto M, Matsubara T, Furukawa S. Analysis of serum soluble CD40 ligand in patients with influenza virus-associated encephalopathy. J Neurol Sci. 2005;239(1):53–7.PubMedCrossRef

39.

Ishigami A, Kubo S, Ikematsu K, Kitamura O, Tokunaga I, Gotohda T, Nakasono I. An adult autopsy case of acute encephalopathy associated with influenza A virus. Leg Med (Tokyo). 2004;6(4):252–5.CrossRef

40.

Ito Y, Ichiyama T, Kimura H, Shibata M, Ishiwada N, Kuroki H, Furukawa S, Morishima T. Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy. J Med Virol. 1999;58(4):420–5.PubMedCrossRef

41.

Iwata A, Matsubara K, Nigami H, Kamimura K, Fukaya T. Reversible splenial lesion associated with novel influenza A (H1N1) viral infection. Pediatr Neurol. 2010;42(6):447–50.PubMedCrossRef

42.

Juurlink DN, Stukel TA, Kwong J, Kopp A, McGeer A, Upshur RE, Manuel DG, Moineddin R, Wilson K. Guillain-Barre syndrome after influenza vaccination in adults: a population-based study. Arch Intern Med. 2006;166(20):2217–21.PubMedCrossRef

43.

Kao CD, Chen JT, Lin KP, Shan DE, Wu ZA, Liao KK. Guillain-Barre syndrome coexisting with pericarditis or nephrotic syndrome after influenza vaccination. Clin Neurol Neurosurg. 2004;106(2):136–8.PubMedCrossRef

44.

Kasai T, Togashi T, Morishima T. Encephalopathy associated with influenza epidemics. Lancet. 2000;355(9214):1558–9.PubMedCrossRef

45.

Kawada J, Kimura H, Hara S, Ito Y, Kawashima H, Okuno T, Morishima T. Absence of associations between influenza-associated encephalopathy and human herpesvirus 6 or human herpesvirus 7. Pediatr Infect Dis J. 2003;22(2):115–9.PubMed

46.

Kawada J, Kimura H, Ito Y, Hara S, Iriyama M, Yoshikawa T, Morishima T. Systemic cytokine responses in patients with influenza-associated encephalopathy. J Infect Dis. 2003;188(5):690–8.PubMedCrossRef

47.

Kawashima H, Togashi T, Yamanaka G, Nakajima M, Nagai M, Aritaki K, Kashiwagi Y, Takekuma K, Hoshika A. Efficacy of plasma exchange and methylprednisolone pulse therapy on influenza-associated encephalopathy. J Infect. 2005;51(2):E53–6.PubMedCrossRef

48.

Kawashima H, Watanabe Y, Ichiyama T, Mizuguchi M, Yamada N, Kashiwagi Y, Takekuma K, Hoshika A, Mori T. High concentration of serum nitrite/nitrate obtained from patients with influenza-associated encephalopathy. Pediatr Int. 2002;44(6):705–7.PubMedCrossRef

49.

Kawashima H, Watanabe Y, Morishima T, Togashi T, Yamada N, Kashiwagi Y, Takekuma K, Hoshika A, Mori T. NOx (nitrite/nitrate) in cerebral spinal fluids obtained from patients with influenza-associated encephalopathy. Neuropediatrics. 2003;34(3):137–40.PubMedCrossRef

50.

Kostianovsky A, Charles P, Alves JF, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. Clin Exp Rheumatol. 2012;30(1 Suppl 70):S83–9.PubMed

51.

Lee N. Acute Encephalopathy Associated with Influenza A Infection in Adults. Emerging Infectious Diseases 2010;16(1).

52.

Lehmann HC, Hartung HP, Kieseier BC, Hughes RA. Guillain-Barre syndrome after exposure to influenza virus. Lancet Infect Dis. 2010;10(9):643–51.PubMedCrossRef

53.

Lyon JB, Remigio C, Milligan T, Deline C. Acute necrotizing encephalopathy in a child with H1N1 influenza infection. Pediatr Radiol. 2010;40(2):200–5.PubMedCrossRef

54.

Martin A, Reade EP. Acute necrotizing encephalopathy progressing to brain death in a pediatric patient with novel influenza A (H1N1) infection. Clin Infect Dis. 2010;50(8):e50–2.PubMedCrossRef

55.

Maurizi CP. Influenza caused epidemic encephalitis (encephalitis lethargica): the circumstantial evidence and a challenge to the nonbelievers. Med Hypotheses. 2010;74(5):798–801.PubMedCrossRef

56.

Mizuguchi M. Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan. Brain Dev. 1997;19(2):81–92.PubMedCrossRef

57.

Mizuguchi M, Yamanouchi H, Ichiyama T, Shiomi M. Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand. 2007;115(4 Suppl):45–56.PubMedCrossRef

58.

Moro PL, Tepper NK, Grohskopf LA, et al. Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy. Expert Rev Vaccines. 2012;11(8):911–21.PubMedCrossRef

59.

Mortimer PP. Was encephalitis lethargica a post-influenzal or some other phenomenon? Time to re-examine the problem. Epidemiol Infect. 2009;137(4):449–55.PubMedCrossRef

60.

Muhammad S, Haasbach E, Kotchourko M, Strigli A, Krenz A, Ridder DA, Vogel AB, Marti HH, Al-Abed Y, Planz O, et al. Influenza virus infection aggravates stroke outcome. Stroke. 2011;42(3):783–91.PubMedCrossRef

61.

Nakamura N, Nokura K, Zettsu T, Koga H, Tachi M, Terada M, Katoh H, Itoh Y, Osawa H, Ozeki T, et al. Neurologic complications associated with influenza vaccination: two adult cases. Intern Med. 2003;42(2):191–4.PubMedCrossRef

62.

Neurologic complications associated with novel influenza A (H1N1) virus infection in children - Dallas, Texas, May 2009. MMWR Morb Mortal Wkly Rep 2009, 58(28):773-778.

63.

Newland JG, Laurich VM, Rosenquist AW, Heydon K, Licht DJ, Keren R, Zaoutis TE, Watson B, Hodinka RL, Coffin SE. Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. J Pediatr. 2007;150(3):306–10.PubMedCrossRef

64.

Ng WF, Chiu SC, Lam DS, Wong YC, Tam S, Kwong NS, Loo KT, Yuen KY. A 7-year-old boy dying of acute encephalopathy. Brain Pathol. 2010;20(1):261–4.PubMedCrossRef

65.

Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003;348(14):1322–32.PubMedCrossRef

66.

Nunoi H, Mercado MR, Mizukami T, Okajima K, Morishima T, Sakata H, Nakayama S, Mori S, Hayashi M, Mori H, et al. Apoptosis under hypercytokinemia is a possible pathogenesis in influenza-associated encephalopathy. Pediatr Int. 2005;47(2):175–9.PubMedCrossRef

67.

Okabe N, Yamashita K, Taniguchi K, Inouye S. Influenza surveillance system of Japan and acute encephalitis and encephalopathy in the influenza season. Pediatr Int. 2000;42(2):187–91.PubMedCrossRef

68.

Okumura A, Abe S, Kidokoro H, Mizuguchi M. Acute necrotizing encephalopathy: a comparison between influenza and non-influenza cases. Microbiol Immunol. 2009;53(5):277–80.PubMedCrossRef

69.

Okumura A, Mizuguchi M, Kidokoro H, Tanaka M, Abe S, Hosoya M, Aiba H, Maegaki Y, Yamamoto H, Tanabe T, et al. Outcome of acute necrotizing encephalopathy in relation to treatment with corticosteroids and gammaglobulin. Brain Dev. 2009;31(3):221–7.PubMedCrossRef

70.

Olgar S, Ertugrul T, Nisli K, Aydin K, Caliskan M. Influenza a-associated acute necrotizing encephalopathy. Neuropediatrics. 2006;37(3):166–8.PubMedCrossRef

71.

Pandemic influenza: a priority for the neurological community. Lancet Neurol 2009; 8(10):869.

72.

Parikh M, Dolson G, Ramanathan V, Sangsiraprapha W. Novel H1N1-associated rhabdomyolysis leading to acute renal failure. Clin Microbiol Infect. 2010;16(4):330–2.PubMedCrossRef

73.

Partinen M, Saarenpaa-Heikkila O, Ilveskoski I, et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS ONE. 2012;7(3):33723.CrossRef

74.

Perez C, Loza E, Tinture T. Giant cell arteritis after influenza vaccination. Arch Intern Med. 2000;160(17):2677.PubMedCrossRef

75.

Preliminary results: surveillance for Guillain-Barre syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010. MMWR Morb Mortal Wkly Rep 2010, 59(21):657-661.

76.

Reid AH, McCall S, Henry JM, Taubenberger JK. Experimenting on the past: the enigma of von Economo’s encephalitis lethargica. J Neuropathol Exp Neurol. 2001;60(7):663–70.PubMed

77.

Ryan MM, Procopis PG, Ouvrier RA. Influenza A encephalitis with movement disorder. Pediatr Neurol. 1999;21(3):669–73.PubMedCrossRef

78.

Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009. MMWR Morb Mortal Wkly Rep 2009, 58(48):1351-1356.

79.

Sakurai T, Kimura A, Tanaka Y, Hozumi I, Ogura S, Inuzuka T. Case of adult influenza type A virus-associated encephalopathy successfully treated with primary multidisciplinary treatments. Rinsho Shinkeigaku. 2007;47(10):639–43.PubMed

80.

Sanchez-Torrent L, Trivino-Rodriguez M, Suero-Toledano P, Claret-Teruel G, Munoz-Almagro C, Martinez-Sanchez L, Jordan-Garcia I, Garcia–Garcia JJ. Novel influenza A (H1N1) encephalitis in a 3-month-old infant. Infection. 2010;38(3):227–9.PubMedCrossRef

81.

Sato S, Kumada S, Koji T, Okaniwa M. Reversible frontal lobe syndrome associated with influenza virus infection in children. Pediatr Neurol. 2000;22(4):318–21.PubMedCrossRef

82.

Shieh WJ, Blau DM, Denison AM, Deleon-Carnes M, Adem P, Bhatnagar J, Sumner J, Liu L, Patel M, Batten B, et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol. 2010;177(1):166–75.PubMedCrossRef

83.

Shiomi M. Pathogenesis of acute encephalitis and acute encephalopathy. Nippon Rinsho. 2011;69(3):399–408.PubMed

84.

Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351(25):2611–8.PubMedCrossRef

85.

Studahl M. Influenza virus and CNS manifestations. J Clin Virol. 2003;28(3):225–32.PubMedCrossRef

86.

Takanashi J. Two newly proposed infectious encephalitis/encephalopathy syndromes. Brain Dev. 2009;31(7):521–8.PubMedCrossRef

87.

Takanashi J, Tada H, Kuroki H, Barkovich AJ. Delirious behavior in influenza is associated with a reversible splenial lesion. Brain Dev. 2009;31(6):423–6.PubMedCrossRef

88.

Takanashi J, Tsuji M, Amemiya K, Tada H, Barkovich AJ. Mild influenza encephalopathy with biphasic seizures and late reduced diffusion. J Neurol Sci. 2007;256(1–2):86–9.PubMedCrossRef

89.

Tokuhira N, Shime N, Inoue M, et al. Mechanically ventilated children with 2009 pandemic influenza A/H1N1: results from the National Pediatric Intensive Care Registry in Japan. Pediatr Crit Care Med. 2012;13(5):e294–8.PubMedCrossRef

90.

Tsuji M, Yoshida T, Miyakoshi C, Haruta T. Is a reversible splenial lesion a sign of encephalopathy? Pediatr Neurol. 2009;41(2):143–5.PubMedCrossRef

91.

van der Vries E, Stelma FF, Boucher CA. Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus. N Engl J Med. 2010;363(14):1381–2.PubMedCrossRef

92.

Vellozzi C, Broder KR, Haber P, Guh A, Nguyen M, Cano M, Lewis P, McNeil MM, Bryant M, Singleton J, et al. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine. 2010;28(45):7248–55.PubMedCrossRef

93.

Watanabe T, Okazaki E, Shibuya H. Influenza A virus-associated encephalopathy with haemophagocytic syndrome. Eur J Pediatr. 2003;162(11):799–800.PubMedCrossRef

94.

Yamanouchi H, Kawaguchi N, Mori M, Imataka G, Yamagata T, Hashimoto T, Momoi MY, Eguchi M, Mizuguchi M. Acute infantile encephalopathy predominantly affecting the frontal lobes. Pediatr Neurol. 2006;34(2):93–100.PubMedCrossRef

95.

Yamanouchi H, Mizuguchi M. Acute infantile encephalopathy predominantly affecting the frontal lobes (AIEF): a novel clinical category and its tentative diagnostic criteria. Epilepsy Res. 2006;70(Suppl 1):S263–8.PubMedCrossRef

96.

Yang J, Wang Y-G, Xu Y-L, Ren X-L, Mao Y, Li X-W. A (H1N1) Influenza Pneumonia with Acute Disseminated Encephalomyelitis: a Case Report. Biomed Environ Sci. 2010;23(4):323–6.PubMedCrossRef

97.

Yao D, Mizuguchi H, Yamaguchi M, Yamada H, Chida J, Shikata K, Kido H. Thermal instability of compound variants of carnitine palmitoyltransferase II and impaired mitochondrial fuel utilization in influenza-associated encephalopathy. Hum Mutat. 2008;29(5):718–27.PubMedCrossRef

98.

Yokota S, Imagawa T, Miyamae T, Ito S, Nakajima S, Nezu A, Mori M. Hypothetical pathophysiology of acute encephalopathy and encephalitis related to influenza virus infection and hypothermia therapy. Pediatr Int. 2000;42(2):197–203.PubMedCrossRef

99.

Zinman L, Thoma J, Kwong JC, Kopp A, Stukel TA, Juurlink DN. Safety of influenza vaccination in patients with myasthenia gravis: a population-based study. Muscle Nerve. 2009;40(6):947–51.PubMedCrossRef

Title: Influenza-Associated Neurological Complications
Authors: Jenny P. Tsai
Andrew J. Baker
Publication date: 01-02-2013
Publisher: Humana Press Inc
Published in: Neurocritical Care / Issue 1/2013
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI: https://doi.org/10.1007/s12028-012-9796-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Influenza-Associated Neurological Complications

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2013

Neuroendocrine Changes in Patients with Spontaneous Supratentorial Intracerebral Hemorrhage

Factors Associated with the Withdrawal of Life-Sustaining Therapies in Patients with Severe Traumatic Brain Injury: A Multicenter Cohort Study

Goal Directed Brain Tissue Oxygen Monitoring Versus Conventional Management in Traumatic Brain Injury: An Analysis of In Hospital Recovery

Randomized, Double-Blind Trial of the Effect of Fluid Composition on Electrolyte, Acid–Base, and Fluid Homeostasis in Patients Early After Subarachnoid Hemorrhage

Symptomatic Cerebral Vasospasm Following Resection of a Medulloblastoma in a Child

A Rule to Identify Patients Who Require Magnetic Resonance Imaging After Intracerebral Hemorrhage